Middle East and Africa In-vitro Diagnostics Market Report and Forecast 2024-2032

Middle East and Africa In-vitro Diagnostics Market Outlook

The Middle East and Africa in-vitro diagnostics market is expected to grow at a CAGR of 3.2% during the period 2024-2032. Analysis of human samples offers physicians with vital information to properly diagnose, treat, and prevent illnesses. Several leading companies offer in-vitro diagnostic (IVD) solutions that deliver rapid, sensitive results while minimizing cost and complexity. Modern in-vitro diagnostics (IVDs) enable better diagnosis for prevention and management of infectious and chronic diseases. These factors are expected to drive market growth.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Likely to be Driven by Need for Efficient and Accurate Diagnostics, and Advancements in Technology

The Middle East and North Africa region is considered a manufacturer’s future high growth market for medical devices. Saudi Arabia, UAE, Turkey and Israel are considered large markets in terms of size and expenditure capacity.

In-vitro means ‘in glass’, indicating that these tests are generally carried out in test tubes and similar equipment, as against in vivo tests, that are performed in the body itself. In-vitro diagnostics may also be employed in precision medicine to determine patients likely to benefit from particular treatments or therapies. These in-vitro diagnostics could include next generation sequencing tests, which scan a person’s DNA to detect genomic variations. Some tests are carried out in a laboratory or other health professional settings, while others may be conducted by consumers at home. The tests themselves can be conducted on a wide range of instruments, varying from small, handheld tests to more complex laboratory instruments.

Introduction of New Technologies and Companies’ Efforts to Provide Better Solutions Expected to Drive Market Growth

Introduction of new technologies and growing penetration of private independent laboratories have led to significant progress in the clinical laboratory segment in the UAE and Saudi Arabia. Thus, there has been a distinct shift towards independent labs from hospital-based laboratories with advancements in technology. Such developments are likely to boost the Middle East and Africa in-vitro diagnostics market. Tests have also become more cost-effective. In 2023, AACC and Life Diagnostics partnered to relaunch AACC Middle East. The two-day conference and exposition would showcase world-class in-vitro diagnostic innovations and clinical laboratory best practices in Dubai, UAE.

Leading companies are offering solutions to enhance instrument performance. For example, Thermo Fisher offers AB Assurance Dx service plan exclusively for IVD instruments; the plan is devised to maintain instrument performance to make sure the availability of important instrument systems in the workflow. The AB Assurance Dx service plan would help keep laboratory operations running efficiently with planned maintenance, qualification services, proactive instrument monitoring (where available), and, in case instruments warrant service, a timely response. This service plan would suit locations such as clinical and IVD laboratories that rely on IVD instruments and the need to decrease production downtime risk.

In-vitro Diagnostics (IVD) and Point of Care Testing (POCT) Likely to Stimulate Market

In-vitro diagnostics (IVD) and point of care testing (POCT) are expected to witness significant growth. There has been considerable growth in demand for rapid, economical, easy-to-use POCT devices for infectious disease diagnostics in the UAE. Such developments are likely to boost the Middle East and Africa in-vitro diagnostics market. Other important areas with significant opportunities for growth include adoption of managed clinical services in the area’s hospitals, smart labs-as-a-service for automation of laboratory services and the need for next-generation sequencing testing for genetic testing.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Middle East and Africa In-vitro Diagnostics Market Segmentation

By product and service, the market is segmented into:

• Reagents and Kits
• Instruments
• Software and Services

By technology, the market is classified into:

• Immunoassay/Immunochemistry
• Clinical Chemistry 
• Molecular Diagnostics
• Haematology
• Microbiology
• Blood Glucose Self Monitoring
• Coagulation and Haemostasis
• Urinalysis
• Others

By application, the market is divided into:

• Infectious Diseases
• Diabetes
• Cardiology
• Oncology
• Autoimmune Diseases
• Nephrology
• Others

By end use, the market is classified into:

• Hospitals
• Laboratories
• Homecare
• Others

By country, the market is segmented into:

• Saudi Arabia
• United Arab Emirates
• Nigeria
• South Africa
• Others

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Industry Players in the Middle East and Africa In-vitro Diagnostics Market

The report presents a detailed analysis of the following key players in the Middle East and Africa in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Becton, Dickinson and Company
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• Surmodics IVD, Inc.
• Illumina, Inc.
• Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report